Explore evidence

15.6 %Among HCV RNA carriers, HCV genotype 3 was detected in 15.6% of individuals.

Burkina Fasohépatite Cpublished 2014Blood transfusion = Trasfusione del sangueeurope_pmcdocument of 5 observations

1.5 %Among 2,200 blood donors, the prevalence of viral RNA was 1.5%.

Burkina Fasohépatite Cpublished 2014Blood transfusion = Trasfusione del sangueeurope_pmcdocument of 5 observations

3.3 %Among 4,520 blood donors in Burkina Faso in 2009, 149 (3.30%) had serological evidence of multiple infections.

Burkina Fasohépatite B · hépatite C · syphilis · VIH/sidaobserved 2009published 2011Blood transfusion = Trasfusione del sangueeurope_pmcdocument of 9 observations

8.69 %The overall seroprevalence rate of HCV among blood donors in Burkina Faso was 8.69%.

Burkina Fasohépatite Cpublished 2011Blood transfusion = Trasfusione del sangueeurope_pmcdocument of 9 observations

4.4 %Among 2,200 blood donors, the prevalence of antibodies to HCV was 4.4%.

Burkina Fasohépatite Cpublished 2014Blood transfusion = Trasfusione del sangueeurope_pmcdocument of 5 observations

6,784.6 per_100000Among 3,981 repeat blood donors in Burkina Faso in 2009, the incidence rate of anti-HCV was 6784.6 per 100000 donations.

Burkina Fasohépatite Cobserved 2009published 2012Tropical medicine & international health : TM & IHeurope_pmcdocument of 9 observationsDOI 10.1111/j.1365-3156.2011.02902.x

0.11 %Among blood donors with multiple infections in Burkina Faso, the most common dual or triple combination was HBsAg-HCV-syphilis at 0.11%.

Burkina Fasohépatite B · hépatite C · syphilispublished 2011Blood transfusion = Trasfusione del sangueeurope_pmcdocument of 9 observations

29.82 %Among 4,520 blood donors in Burkina Faso in 2009, 1,348 (29.82%) were infected with at least one pathogen.

Burkina Fasohépatite B · hépatite C · syphilis · VIH/sidaobserved 2009published 2011Blood transfusion = Trasfusione del sangueeurope_pmcdocument of 9 observations

6.3 %The seroprevalence of HCV in first-time volunteer blood donors in Burkina Faso in 2009 was 6.3%.

Burkina Fasohépatite Cobserved 2009published 2012Tropical medicine & international health : TM & IHeurope_pmcdocument of 9 observationsDOI 10.1111/j.1365-3156.2011.02902.x

2.2 %HCV and HBV coinfection was 2.2% among the 462 screened patients at Saint Camille Medical Centre.

Burkina Fasohépatite B · hépatite Cobserved 2012published 2012Pakistan journal of biological sciences : PJBSeurope_pmcdocument of 8 observations

3.9 %HCV prevalence was 3.9% among the 462 screened patients at Saint Camille Medical Centre.

Burkina Fasohépatite Cobserved 2012published 2012Pakistan journal of biological sciences : PJBSeurope_pmcdocument of 8 observations

1.39 %Among blood donors with multiple infections in Burkina Faso, the most common dual or triple combination was HBsAg-HCV at 1.39%.

Burkina Fasohépatite B · hépatite Cpublished 2011Blood transfusion = Trasfusione del sangueeurope_pmcdocument of 9 observations

900 deaths/yearHepatitis C virus is responsible for about 900 deaths every year in Burkina Faso.

Burkina Fasohépatite Cpublished 2014Blood transfusion = Trasfusione del sangueeurope_pmcdocument of 5 observations

2,000 deathsHCV and HBV cause 2000 deaths from liver cancer annually in Burkina Faso.

Burkina Fasocarcinome hépatocellulaire · hépatite B · hépatite Cpublished 2012Pakistan journal of biological sciences : PJBSeurope_pmcdocument of 8 observations

56.3 %Among HCV RNA carriers, HCV genotype 2 was detected in 56.3% of individuals.

Burkina Fasohépatite Cpublished 2014Blood transfusion = Trasfusione del sangueeurope_pmcdocument of 5 observations